Please use this identifier to cite or link to this item:
Title: Contralateral adrenal metastasis of renal cell carcinoma: Treatment, outcome and a review
Authors: Lau, W.K 
Zincke, H
Lohse, C.M
Cheville, J.C
Weaver, A.L
Blute, M.L
Keywords: adrenal metastasis
cancer surgery
cancer survival
cause of death
clinical article
controlled study
disease course
follow up
human tissue
kidney carcinoma
medical record
priority journal
retrospective study
treatment outcome
Adrenal Gland Neoplasms
Aged, 80 and over
Carcinoma, Renal Cell
Kidney Neoplasms
Middle Aged
Neoplasms, Second Primary
Retrospective Studies
Survival Analysis
Treatment Outcome
Issue Date: 2003
Citation: Lau, W.K, Zincke, H, Lohse, C.M, Cheville, J.C, Weaver, A.L, Blute, M.L (2003). Contralateral adrenal metastasis of renal cell carcinoma: Treatment, outcome and a review. BJU International 91 (9) : 775-779. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: OBJECTIVE: To report the surgical treatment of patients with renal cell carcinoma (RCC) metastatic to the contralateral adrenal gland and compare our experience with previous reports, as such metastases are found in 2.5% of patients with metastatic RCC at autopsy, and the role of resecting metastatic RCC at this site is not well defined. PATIENTS AND METHODS: We retrospectively identified 11 patients who had surgery for metastatic RCC to the contralateral adrenal gland between October 1978 and April 2001. The patients' medical records were reviewed for clinical, surgical and pathological features, and the patients' outcome. RESULTS: The mean (median, range) age of the patients at primary nephrectomy was 60.9 (64, 43-79) years; all had clear cell (conventional) RCC. Synchronous contralateral adrenal metastasis occurred in two patients. The mean (median, range) time to contralateral adrenal metastasis after primary nephrectomy for the remaining nine patients was 5.2 (6.1, 0.8-9.2) years. All patients were treated with adrenalectomy; there were no perioperative complications or mortality. Seven patients died from RCC at a mean (median, range) of 3.9 (3.7, 0.2-10) years after adrenalectomy for contralateral adrenal metastasis; one died from other causes at 3.4 years, one from an unknown cause at 1.7 years and two were still alive at the last follow-up. CONCLUSIONS: The surgical resection of contralateral adrenal metastasis from RCC is safe; although most patients died from RCC, survival may be prolonged in individual patients. Hence, in the era of cytoreductive surgery, the removal of solitary contralateral adrenal metastasis seems to be indicated.
Source Title: BJU International
ISSN: 14644096
DOI: 10.1046/j.1464-410X.2003.04237.x
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1046_j_1464-410X_2003_04237_x.pdf86.92 kBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons